Anomalous expression of miR-103 in polycystic ovary syndrome influenced by hormonal, and metabolic variables.


Journal

Experimental and molecular pathology
ISSN: 1096-0945
Titre abrégé: Exp Mol Pathol
Pays: Netherlands
ID NLM: 0370711

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 04 2020
revised: 21 05 2020
accepted: 01 06 2020
pubmed: 7 6 2020
medline: 16 12 2020
entrez: 7 6 2020
Statut: ppublish

Résumé

Polycystic ovary syndrome (PCOS), a common endocrine disorder in reproductive-aged women, is correlated with obesity and insulin resistance (IR), androgens excess, chronic anovulation, and infertility. MicroRNAs (miRNAs) are small, single-stranded, noncoding RNA molecules that participate in inflammation, reproduction and metabolism, may contribute to PCOS. Current study aiming to manifest the correlation of body mass index (BMI) and testosterone (T) with miR-103 expression before and after fat loss. 46 controls (N = 23 with BMI < 24 kg/m miR-103 was correlated with BMI rather than testosterone (T), and there was a significant difference between the non-obese and obese groups in miR-103 expression. Compared to before fat loss, miR-103 expression showed a slight downward trend. Serum miR-103 differentially expressed between controls and PCOS subjects, miR-103 was positively correlated with BMI. There was significant difference between the non-obese and obese groups in miR-103 expression.

Sections du résumé

BACKGROUND
Polycystic ovary syndrome (PCOS), a common endocrine disorder in reproductive-aged women, is correlated with obesity and insulin resistance (IR), androgens excess, chronic anovulation, and infertility. MicroRNAs (miRNAs) are small, single-stranded, noncoding RNA molecules that participate in inflammation, reproduction and metabolism, may contribute to PCOS. Current study aiming to manifest the correlation of body mass index (BMI) and testosterone (T) with miR-103 expression before and after fat loss.
METHODS
46 controls (N = 23 with BMI < 24 kg/m
RESULTS
miR-103 was correlated with BMI rather than testosterone (T), and there was a significant difference between the non-obese and obese groups in miR-103 expression. Compared to before fat loss, miR-103 expression showed a slight downward trend.
CONCLUSIONS
Serum miR-103 differentially expressed between controls and PCOS subjects, miR-103 was positively correlated with BMI. There was significant difference between the non-obese and obese groups in miR-103 expression.

Identifiants

pubmed: 32504622
pii: S0014-4800(20)30438-X
doi: 10.1016/j.yexmp.2020.104482
pii:
doi:

Substances chimiques

Blood Glucose 0
Insulin 0
MIRN103 microRNA, human 0
MicroRNAs 0
Testosterone 3XMK78S47O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104482

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Jiawei Mu (J)

Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

Qiang Li (Q)

Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: yuanlaisini@outlook.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH